SPYRE THERAPEUTICS INC (SYRE) Institutional Shareholders

SPYRE THERAPEUTICS INC (SYRE) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $4.10B in SYRE holdings during the latest filing period.

Fmr Llc is currently the largest disclosed institutional shareholder of SYRE tracked by InsiderSet, reporting ownership valued at approximately $594.23M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $1.16B, representing an estimated gain of +94.94% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 53% of the total disclosed SYRE value among the investors covered in this analysis. Major shareholders include Fmr Llc, Blackrock, Inc., Rtw Investments, Lp, and several other long-term asset managers with concentrated positions in SPYRE THERAPEUTICS INC (SYRE).

This page ranks the largest institutional SYRE shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

198

Total Reported Value

$4.10B

Largest Holder

Fmr Llc

Largest Position

$594.23M

Insider Transactions (90d)

23

Latest Filing Quarter

Q2 2026

New Institutional Positions

166

Funds Exiting Positions

1

Page 1 of 4
NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Fmr Llc0.03%11,781,024$594,234,851$1,158,428,090+$564,193,239+94.94%
Blackrock, Inc.0.00%5,521,221$278,490,385$542,901,661+$264,411,276+94.94%
Rtw Investments, Lp2.09%4,171,996$210,435,478$410,232,367+$199,796,889+94.94%
Fairmount Funds Management Llc14.64%4,018,101$202,673,014$395,099,871+$192,426,857+94.94%
Perceptive Advisors Llc3.77%3,783,225$190,825,869$372,004,514+$181,178,645+94.94%
Venrock Adviser, Llc6.94%3,685,448$185,893,997$362,390,102+$176,496,105+94.94%
Vanguard Capital Management Llc0.00%3,057,401$154,215,306$300,634,240+$146,418,934+94.94%
Driehaus Capital Management Llc1.03%2,790,785$140,767,195$274,417,889+$133,650,694+94.94%
State Street Corp0.00%2,607,031$131,498,644$256,349,358+$124,850,714+94.94%
Paradigm Biocapital Advisors Lp2.02%1,957,266$98,724,497$192,457,966+$93,733,469+94.94%
Commodore Capital Lp5.58%1,912,380$96,460,447$188,044,325+$91,583,878+94.94%
Remedium Capital Partners, Llc30.09%1,907,327$96,205,574$187,547,464+$91,341,890+94.94%
Tcg Crossover Management, Llc2.74%1,900,582$95,865,356$186,884,228+$91,018,872+94.94%
Tang Capital Management Llc4.85%1,892,200$95,442,568$186,060,026+$90,617,458+94.94%
Wellington Management Group Llp0.02%1,824,811$92,043,467$179,433,666+$87,390,199+94.94%
Capital International Investors0.02%1,746,129$88,074,747$171,696,865+$83,622,118+94.94%
Geode Capital Management, Llc0.01%1,720,912$86,819,367$169,217,277+$82,397,910+94.91%
Janus Henderson Group Plc0.04%1,656,164$83,586,597$162,850,606+$79,264,009+94.83%
Ra Capital Management, L.P.0.87%1,621,620$81,794,513$159,453,895+$77,659,382+94.94%
Affinity Asset Advisors, Llc3.78%1,279,134$64,519,519$125,777,246+$61,257,727+94.94%
Bank Of America Corp0.00%1,228,093$61,945,011$120,758,385+$58,813,374+94.94%
Pictet Asset Management Holding Sa0.05%628,138$55,766,092$61,764,810+$5,998,718+10.76%
Baker Bros. Advisors Lp0.29%1,000,000$50,440,000$98,330,000+$47,890,000+94.94%
Braidwell Lp1.57%932,823$47,051,592$91,724,486+$44,672,894+94.94%
Franklin Resources Inc0.01%882,833$44,530,096$86,808,969+$42,278,873+94.94%
Caligan Partners Lp3.13%878,127$44,292,726$86,346,228+$42,053,502+94.94%
Siren, L.L.C.1.14%818,598$41,290,083$80,492,741+$39,202,658+94.94%
Polar Capital Holdings Plc0.17%792,847$39,991,203$77,960,646+$37,969,443+94.94%
Ubs Group Ag0.01%671,235$33,857,093$66,002,538+$32,145,445+94.94%
Capital World Investors0.00%666,564$33,621,488$65,543,238+$31,921,750+94.94%
Emerald Advisers, Llc0.98%613,365$30,938,131$60,312,180+$29,374,049+94.94%
Candriam S.C.A.0.16%610,282$30,782,624$60,009,029+$29,226,405+94.94%
Vanguard Portfolio Management Llc0.00%585,130$29,513,957$57,535,833+$28,021,876+94.94%
Northern Trust Corp0.00%578,907$29,200,068$56,923,925+$27,723,857+94.94%
Charles Schwab Investment Management Inc0.00%562,653$28,380,217$55,325,669+$26,945,452+94.94%
Vanguard Fiduciary Trust Co0.01%464,651$23,436,996$45,689,133+$22,252,137+94.94%
Emerald Mutual Fund Advisers Trust1.00%408,113$20,585,220$40,129,751+$19,544,531+94.94%
Samlyn Capital, Llc0.34%396,661$20,007,581$39,003,676+$18,996,095+94.94%
Adar1 Capital Management, Llc1.03%338,323$17,065,012$33,267,301+$16,202,289+94.94%
Blackstone Inc.0.06%292,847$14,771,203$28,795,646+$14,024,443+94.94%
Victory Capital Management Inc0.01%292,126$14,734,836$28,724,750+$13,989,914+94.94%
Goldman Sachs Group Inc0.00%269,938$13,615,673$26,543,004+$12,927,331+94.94%
Woodline Partners Lp0.05%265,892$13,411,592$26,145,160+$12,733,568+94.94%
Morgan Stanley0.00%246,719$12,444,525$24,259,879+$11,815,354+94.94%
Ubs Am, A Distinct Business Unit Of Ubs Asset Management Americas Llc0.00%207,314$10,456,918$20,385,186+$9,928,268+94.94%
Boothbay Fund Management, Llc0.22%193,031$9,736,484$18,980,738+$9,244,254+94.94%
Bank Of New York Mellon Corp0.00%191,395$9,653,965$18,819,870+$9,165,905+94.94%
Silverarc Capital Management, Llc1.11%186,618$9,413,012$18,350,148+$8,937,136+94.94%
First Trust Advisors Lp0.01%178,389$8,997,941$17,540,990+$8,543,049+94.94%
Universal- Beteiligungs- Und Servicegesellschaft Mbh0.01%170,381$8,594,017$16,753,564+$8,159,547+94.94%

Frequently asked questions about SYRE

  • Who owns the most SYRE stock?

    The largest holders of SYRE are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for SPYRE THERAPEUTICS INC (SYRE).

  • Is SYRE widely held by superinvestors?

    Many widely followed stocks like SYRE appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly SYRE is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.